Skip to content
Screener

STERIS STE Q3 2026 earnings

Reported February 4, 2026 · After market close

Revenue$1.5BBeat by $15.3M
EPS$2.53In line
Revenue estimate$1.5B
EPS estimate$2.53

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$1.6B
EPS estimate$2.68

Financials

Q3 2026

Income statement

See full
Revenue$1.5B+9.2%
Gross profit$655.5M+7.4%
Operating income$273.2M+11.4%
Net income$192.9M+11.2%
EPS (diluted)$1.96+12.0%

Balance sheet

See full
Cash & equivalents$423.7M+173%
Total debt$1.9B-16.7%
Total equity$7.2B+11.5%
Total assets$10.6B+5.8%

Cash flow

See full
Operating cash flow$298.2M-10.4%
CapEx$98.7M+10.7%
Free cash flow$199.5M-18.1%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$24.88B+22.6%
Enterprise value$26.39B+17.5%
P/E35.2×-8.2×
P/S4.3×+0.5×

Profitability

See full
Gross margin44.1%+0.7pp
Operating margin17.2%+1.0pp
Net margin12.1%+3.5pp
FCF margin15.7%+1.8pp

Returns & leverage

See full
Return on equity10.4%+3.1pp
Debt / equity0.3×-0.1×
Current ratio2.5×+0.3×

Segments

By segment

See full
Healthcare$1.1B—
Applied Sterilization Technologies$286.6M+11.0%
Life Sciences:$145.8M—

By product

See full
Service$717.6M+9.9%
Consumables$463.0M+8.5%
Capital equipment$315.6M+8.5%

FAQ

When did STERIS report Q3 2026 earnings?
STERIS (STE) reported Q3 2026 earnings on February 4, 2026 after market close.
What were STERIS's Q3 2026 revenue and EPS?
STERIS reported revenue of $1.5B and eps of $2.53 for Q3 2026.
Did STERIS beat estimates in Q3 2026?
Revenue beat the consensus estimate of $1.5B by $15.3M. EPS beat the consensus estimate of $2.53 by $0.00.
How did STERIS's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.2% from $1.4B a year earlier and eps grew 9.1% from $2.32.
Where can I find STERIS's Q3 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-005473) and the 10-Q periodic report (0001628280-26-006055) directly on SEC EDGAR. The filing index links above go to sec.gov.